Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Very Frustrating To Watch Rise Then Pullback In SHaew Price

<< Previous

Bullboard Posts

Next >>

Post by blinkieon Feb 19, 2021 2:45pm

211 Views

Post# 32611946

Very Frustrating To Watch Rise Then Pullback In SHaew Price

Even though I (we) all understand this is a 'game' for that group(s) that are accumulating the shares it is a little disheartening to see the ongoing increases and then the pullbacks.

Most of us believe news is coming shortly based on Managements comments during the AGM & alluded to again in the Skymount Medical press release.

Personally I just want ICO to get on with it!

As well IF people would stop selling their shares cheaply then we will all be better off.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"